Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
100.31
+3.14 (3.23%)
At close: May 12, 2025, 4:00 PM
98.35
-1.96 (-1.95%)
After-hours: May 12, 2025, 4:25 PM EDT
Blueprint Medicines (BPMC) Revenue by Segment
History
| Date | Product | Collaboration License and Other | License Related |
|---|---|---|---|
| Mar 31, 2025 | 535.84M | - | - |
| Dec 31, 2024 | 478.95M | 29.87M | - |
| Sep 30, 2024 | 405.86M | - | - |
| Jun 30, 2024 | 331.90M | 30.89M | - |
| Mar 31, 2024 | 257.66M | 24.55M | - |
| Dec 31, 2023 | 204.21M | 45.17M | - |
| Sep 30, 2023 | 163.24M | 52.97M | - |
| Jun 30, 2023 | 137.64M | 60.47M | - |
| Mar 31, 2023 | 126.22M | 50.87M | - |
| Dec 31, 2022 | 110.99M | 65.54M | - |
| Sep 30, 2022 | 100.96M | 143.82M | 27.50M |
| Jun 30, 2022 | 89.59M | 140.89M | - |
| Mar 31, 2022 | 72.57M | 148.66M | - |
| Dec 31, 2021 | 57.69M | 122.39M | - |
| Sep 30, 2021 | 44.35M | 62.82M | - |
| Jun 30, 2021 | 33.38M | 794.71M | - |
| Mar 31, 2021 | 27.63M | 781.51M | - |
| Dec 31, 2020 | 22.13M | 771.60M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.